Journal of Genetic Syndromes & Gene Therapy
Open Access

ISSN: ISSN: 2157-7412

Journal of Genetic Syndromes & Gene Therapy : Citations & Metrics Report

Articles published in Journal of Genetic Syndromes & Gene Therapy have been cited by esteemed scholars and scientists all around the world. Journal of Genetic Syndromes & Gene Therapy has got h-index 23, which means every article in Journal of Genetic Syndromes & Gene Therapy has got 23 average citations.

Following are the list of articles that have cited the articles published in Journal of Genetic Syndromes & Gene Therapy.

	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Total published articles	15	32	31	25	8	2	1	8	40	28	44	99	43	14
Research, Review articles and Editorials	1	0	3	13	3	1	1	6	20	21	33	69	21	13
Research communications, Review communications, Editorial communications, Case reports and Commentary	14	32	27	9	4	1	0	2	16	7	11	22	4	1
Conference proceedings	0	0	0	0	0	0	61	64	56	0	0	0	52	0
Citations received as per Google Scholar, other indexing platforms and portals	118	167	197	209	211	248	217	322	324	339	198	122	53	21

Journal total citations count	2102
Journal impact factor	5.89
Journal 5 years impact factor	13.25
Journal cite score	20.22
Journal h-index	23
Journal h-index since 2019	16

Important citations (187)

falsini s, ciani l, ristori s, fortunato a, arcangeli a (2014) advances in lipid-based platforms for rnai therapeutics. j med chem 57: 1138-46. View at Publisher View at Google Scholar
di gioia s, trapani a, castellani s, carbone a, belgiovine g, et al. (2015) nanocomplexes for gene therapy of respiratory diseases: targeting and overcoming the mucus barrier. pulmonary pharmacology & therapeutics 34: 8-24. View at Publisher View at Google Scholar
sarkar d, perrin gq, zolotukhin s, srivastava a, herzog rw (2013) gene therapists determined to stop the bleeding!. journal of genetic syndromes & gene therapy 1:1. View at Publisher View at Google Scholar
herzog rw, daniell h (2014), inventors; the trustees of the university of pennsylvania, university of florida research foundation, inc., assignee. compositions and methods for suppression of inhibitor formation against coagulation factors in hemophilia patients. united states patent application us 15/037,045. View at Publisher View at Google Scholar
fellmann c, gowen bg, lin pc, doudna ja, corn je (2016) cornerstones of crispr-cas in drug discovery and therapy. nature reviews drug discovery. View at Publisher View at Google Scholar
factor vi. suppression of inhibitor formation against fviii in a murine model of hemophilia a by oral delivery of antigens bioencapsulated in plant cells. View at Publisher View at Google Scholar
mao j, xi x, kapranov p, dong b, firrman j, et al. (2013) in vitro and in vivo model systems for hemophilia a gene therapy. journal of genetic syndromes & gene therapy. View at Publisher View at Google Scholar
sherman a, su j, lin s, wang x, herzog rw, ët al (2014). suppression of inhibitor formation against fviii in a murine model of hemophilia a by oral delivery of antigens bioencapsulated in plant cells. blood 124: 1659-68. View at Publisher View at Google Scholar
sahin u, karikó k, türeci ö (2014) mrna-based therapeutics—developing a new class of drugs. nature reviews drug discovery 13: 759-80. View at Publisher View at Google Scholar
matrai j, chuah m, vandendriessche t (2012) advances and future perspectives in lentiviral gene therapy for hemophilia a and b. journal of genetic syndromes and gene therapy 1. View at Publisher View at Google Scholar
de sousa bomfim a, de freitas mc, picanço-castro v, neto md, swiech k, et al. (2016) human cell lines: a promising alternative for recombinant fix production. protein expression and purification 121: 149-56. View at Publisher View at Google Scholar
sarkar d, perrin gq, zolotukhin s, srivastava a, herzog rw (2013) gene therapists determined to stop the bleeding!. journal of genetic syndromes & gene therapy 1:1. View at Publisher View at Google Scholar
herzog rw, daniell h (2014) inventors; the trustees of the university of pennsylvania, university of florida research foundation, inc., assignee. compositions and methods for suppression of inhibitor formation against coagulation factors in hemophilia patients. united states patent application us 15/037,045. View at Publisher View at Google Scholar
kumar l, varghese r, menon rn, siddharthan n (2015) perioperative management of a patient with severe haemophilia b for abdominal pseudotumour surgery. indian journal of anaesthesia 59: 461. View at Publisher View at Google Scholar
marlina d, reniarti l, veronica f (2017) five-year data of clinical characteristics and laboratory findings of hospitalized hemophilic patients in dr. hasan sadikin general hospital. althea medical journal 3: 605-9. View at Publisher View at Google Scholar
factor vi. suppression of inhibitor formation against fviii in a murine model of hemophilia a by oral delivery of antigens bioencapsulated in plant cells. View at Publisher View at Google Scholar
sherman a, su j, lin s, wang x, herzog rw, et al. (2014) suppression of inhibitor formation against fviii in a murine model of hemophilia a by oral delivery of antigens bioencapsulated in plant cells. blood 124: 1659-68. View at Publisher View at Google Scholar
alabdulkareem i, abdi s, aifawaz m, albalwi m (2011) lmx1b gene mutation in a saudi patient with bilateral symmetrical hypoplastic nails of the hands. j genet syndr gene ther 2. View at Publisher View at Google Scholar
zakas pm, spencer ht, doering cb (2011). engineered hematopoietic stem cells as therapeutics for hemophilia a. journal of genetic syndromes & gene therapy 1. View at Publisher View at Google Scholar
greene tk, lambert mp, poncz m (2011). ectopic platelet-delivered factor (f) viii for the treatment of hemophilia a: plasma and platelet fviii, is it all the same?. journal of genetic syndromes & gene therapy 12. View at Publisher View at Google Scholar
Prev 1 2 3 4 5 6 7 8 9 10 Next »

Top